Home › Medidata And PPD Partner To Offer New Approach To Risk-Based Monitoring
 

Keywords :   


Medidata And PPD Partner To Offer New Approach To Risk-Based Monitoring

2014-11-05 05:42:12| drugdiscoveryonline Home Page

Medidata, a leading global provider of cloud-based solutions for clinical research in life sciences, and Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), recently announced they are expanding their partnership to provide the life science industry with a more comprehensive approach to risk-based monitoring (RBM)—aimed at conducting drug development more intelligently, more quickly and more cost-effectively

Tags: to offer partner approach

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.10Would Donald Trumps taxes on trade hurt US consumers?
15.10Atlantic Tropical Weather Outlook
15.10Eastern North Pacific Tropical Weather Outlook
15.10African nations race to put satellites in space
15.10American equal pay icon Lilly Ledbetter dies aged 86
14.10All Printing Resources and Omet to host Fall Technology Summit
14.10Farmer sentenced to prison in cattle theft and bankruptcy fraud scheme
14.10Ranchbot Monitoring Solutions appoints new advisory board
More »